Latest News about INCY
Recent news which mentions INCY
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
August 15, 2024
From Benzinga
After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial
July 31, 2024
From Benzinga
Incyte's Q2 Earnings: Wider Than Expected Loss, Pipeline Review, Lifts Jakafi Sales Guidance
July 30, 2024
From Benzinga
From Benzinga
From InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
From InvestorPlace
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
From InvestorPlace
From Benzinga
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
From InvestorPlace
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
June 13, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
From Benzinga
Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI
May 24, 2024
From Benzinga
From Benzinga
From Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
From InvestorPlace
Tickers
INCY
From InvestorPlace
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
April 23, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
From InvestorPlace
Exit Now! 3 Biotech Stocks to Sell in February 2024
February 21, 2024
From InvestorPlace
Earnings Scheduled For February 13, 2024
February 13, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.